(CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bruce Eric Sands
Massachusetts General Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
105 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Santarus Clinical Investigational Site 6005
Abbotsford British Columbia, British Columbia, Canada
- Santarus Clinical Investigational Site 6000
Vancouver, British Columbia, Canada
- Santarus Clinical Investigational Site 6014
Vancouver, British Columbia, Canada
- Santarus Clinical Investigational Site 6008
Victoria, British Columbia, Canada
- Santarus Clinical Investigational Site 6004
Richmond Hill, Ontario, Canada
- Santarus Clinical Investigational Site 6017
Toronto, Ontario, Canada
- Santarus Clinical Investigational Site 6001
Montreal, Quebec, Canada
- Santarus Clinical Investigational Site 6002
Québec, Quebec, Canada
- Santarus Clinical Investigational Site 6016
Saskatoon, Saskatchewan, Canada
- Santarus Clinical Investigational Site 6006
Toronto, Canada
- Santarus Clinical Investigational Site 9001
Andhra Pradesh, India
- Santarus Clinical Investigational Site 9009
Andhra Pradesh, India
- Santarus Clinical Investigational Site 9012
Andhra Pradesh, India
- Santarus Clinical Investigational Site 9016
Andhra Pradesh, India
- Santarus Clinical Investigational Site 9006
Assam, India
- Santarus Clinical Investigational Site 9007
Gujarat, India
- Santarus Clinical Investigational Site 9004
Karnataka, India
- Santarus Clinical Investigational Site 9015
Karnataka, India
- Santarus Clinical Investigational Site 9003
Kerala, India
- Santarus Clinical Investigational Site 9002
Maharashtra, India
- Santarus Clinical Investigational Site 9008
Maharashtra, India
- Santarus Clinical Investigational Site 9010
Maharashtra, India
- Santarus Clinical Investigational Site 9011
Maharashtra, India
- Santarus Clinical Investigational Site 9013
Maharashtra, India
- Santarus Clinical Investigational Site 9017
Maharashtra, India
- Santarus Clinical Investigational Site 9018
Rajasthan, India
- Santarus Clinical Investigational Site 9005
Tamil Nadu, India
- Santarus Clinical Investigational Site 9014
Uttar Pradesh, India
- Santarus Clinical Investigational Site 7000
Central, La Paz Baja California Sur, Mexico
- Santarus Clinical Investigational Site 5051
Huntsville, Alabama, United States
- Santarus Clinical Investigational Site 5102
Mobile, Alabama, United States
- Santarus Clinical Investigational Site 5014
Sylacauga, Alabama, United States
- Santarus Clinical Investigational Site 5088
Tucson, Arizona, United States
- Santarus Clinical Investigational Site 5044
Anaheim, California, United States
- Santarus Clinical Investigational Site 5099
Encinitas, California, United States
- Santarus Clinical Investigational Site 5075
Fremont, California, United States
- Santarus Clinical Investigational Site 5087
Lakewood, California, United States
- Santarus Clinical Investigational Site 5033
Los Angeles, California, United States
- Santarus Clinical Investigational Site 5070
Palm Springs, California, United States
- Santarus Clinical Investigational Site 5067
San Diego, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2008
- Primary completion
- 31 May 2010
- Completion
- 30 Jun 2010
- Last update posted
- 10 Dec 2019
- Registered enrollment
- 510
- Registry id
- NCT00679432
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.